(Q34134303)

31 July 2017

1 reference

title

Cyclooxygenase-2--specific inhibitors: are they safe? (English)

1 reference

31 July 2017

Schnitzer TJ

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

American Journal of Medicine

31 July 2017

published in

1 reference

31 July 2017

volume

110

1 reference

31 July 2017

issue

1A

1 reference

31 July 2017

page(s)

46S-49S

1 reference

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Are surrogate markers adequate to assess cardiovascular disease drugs?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthriti

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Update on aspirin in the treatment and prevention of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Cyclooxygenase 2 and wound healing in the stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Prostaglandins: critical roles in pregnancy and colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Multiple female reproductive failures in cyclooxygenase 2-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

Prostaglandins and reproduction--what do knockouts really tell us?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900650-1

10.1016/S0002-9343(00)00650-1

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference